Stocks in play: Medexus Pharmaceuticals Inc.
Announced that CEO Ken d’Entremont, and Chief Financial Officer Marcel Konrad will be presenting at the H.C. Wainwright BioConnect 2022 Conference being held virtually January 10-13. Medexus Pharmaceuticals Inc. shares T.MDP are trading up $0.04 at $2.76.
Read:
As Crypto Mining Undergoes a Sustainable Renaissance, Newer, Greener Operations Arise
Oncology Drug Developers Looking at Significant Projected Growth Through 2030
Plant-Based Meats Continue to Sprout Growing Revenues on Year-Over-Year Basis
No Apparent Need to Panic Over Omicron as Vaccine Developers Are on the Case
Plant-Based Meats Market Projected to Hit $162 Billion by 2030, as New Products Launch